Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.

Iris ZalaudekPaola CorneliSibil VernoniDahlia FedeleGiovanni PapaConforti ClaudioChiara RetrosiRoberta VezzoniSerena FagottiMichela LongoneEleonora FarinazzoNicola di MeoMaria A Pizzichetta

Published in: Dermatologic therapy (2019)

Keyphrases

squamous cell carcinoma
small cell lung cancer
lymph node metastasis
advanced non small cell lung cancer
locally advanced
radiation therapy